Cargando…
Preliminary In Vivo Safety Evaluation of a Tacrolimus Eye Drop Formulation Using Hydroxypropyl Beta Cyclodextrin After Ocular Administration in NZW Rabbits
AIM: Tacrolimus is an immunosuppressive drug with higher potency compared to cyclosporine A (as a useful immunosuppressant). We prepared an ophthalmic solution formulation of Tacrolimus using hydroxypropyl beta cyclodextrin (HP-ßCD). In the present study, safety of this formulation was investigated...
Autores principales: | Mahmoudi, Asma, Malaekeh-Nikouei, Bizhan, Hanafi-Bojd, Mohammad Yahya, Toloei, Mojtaba, Hosseini, Mehran, Nikandish, Malihe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108877/ https://www.ncbi.nlm.nih.gov/pubmed/32273679 http://dx.doi.org/10.2147/OPTH.S229405 |
Ejemplares similares
-
Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop
por: García-Otero, Xurxo, et al.
Publicado: (2021) -
Preparation and in vivo evaluation of nanoliposomes containing vancomycin after intravitreal injection in albino rabbits
por: Abrishami, Majid, et al.
Publicado: (2020) -
Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model
por: García-Otero, Xurxo, et al.
Publicado: (2021) -
Solid Lipid Nanoparticles Improve the Diclofenac Availability in Vitreous after Intraocular Injection
por: Abrishami, Mojtaba, et al.
Publicado: (2016) -
A brief report on Iranian Journal of Basic Medical Sciences in 2013
por: Malaekeh-Nikouei, Bizhan
Publicado: (2014)